Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Shares of Sarepta Therapeutics surged Tuesday morning after the company said it had been informed by the Food and Drug Administration that it could resume shipping a drug it paused sales of last week.

The MLP has a growth wave coming down the pipeline.

Enterprise Products Partners ' ( EPD 0.24%) consistency was on display once again in Q2, with the company reporting solid ...

Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President ...

Palantir Technologies just got a massive price target bump. Loop Capital’s Mark Schappel raised his price target to $178 from ...

The Dow Jones index dipped on the stock market today. President Trump spoke on tariffs. Tesla popped after Elon Musk touted ...